CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
🟢 Connect Biopharma is trading 9.6% up in pre-market
Connect Biopharma is trading 9.6% up at $2.50, though no confirmed company-specific catalyst was identified for August 21, 2026. - The latest material update...
🟢 Connect Biopharma is trading 9.6% up in pre-market with no confirmed company-specific catalyst
Connect Biopharma is trading 9.6% up at $2.50 after no confirmed company-specific catalyst was identified for August 21, 2026. - Its latest material update...
🟢 Connect Biopharma is trading 9.2% up in pre-market with no confirmed catalyst
Connect Biopharma is trading 9.2% up in pre-market at $2.49, with no confirmed catalyst identified. - It closed at $2.28 on August 20, 2026. - No new...
🔴 Connect Biopharma is trading 5.24% down today after broader biotech weakness
Connect Biopharma is trading 5.24% down at $2.33 after broader biotech weakness and profit-taking pressured the sector on August 20, 2026. - Biotech ETF XBI...
🟢 Connect Biopharma is trading 6.1% up today amid biopharma rally after positive melanoma vaccine results
Connect Biopharma is trading 6.1% up now at $2.61, with the move appearing sector-driven after positive Phase 3 melanoma vaccine results from Moderna and...
🟢 Connect Biopharma rises 5.3% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🟢 Connect Biopharma is trading 6.44% up in pre-market with no verified company-specific catalyst identified
Connect Biopharma is trading 6.44% up at $2.59 in pre-market, with no verified company-specific catalyst identified for August 19, 2026. - On August 12,...
🟢 Connect Biopharma is trading 6.69% up today in pre-market with no verified company-specific catalyst identified
Connect Biopharma is trading 6.69% up at $2.66 after no verified company-specific catalyst was identified for August 18, 2026. - The latest material...
🟢 Connect Biopharma is trading 6.43% up today in after-hours trading with no verified late-breaking catalyst identified
Connect Biopharma is trading at $2.65, up 6.43%, after no verified late-breaking catalyst was identified. - It closed at $2.49 on August 17, 2026; no new...
🟢 Connect Biopharma is trading 5.6% up in pre-market after completing Phase 2 enrollment
Connect Biopharma is trading 5.6% up in pre-market at $2.69 as investors continued reacting to its August 12 earnings update. - Completed enrollment in both...
🔴 Connect Biopharma is trading 5% down today after mixed second-quarter results and a widening net loss
Connect Biopharma is trading 5% down now at $2.41 after mixed second-quarter results and a widened net loss. - Collaboration revenue: $2.8 million, above...
🟢 Connect Biopharma is trading 10.3% up today after Q2 EPS beat
Connect Biopharma is trading 10.3% up at $2.57 after reporting second-quarter 2026 results on August 12, including $2.8 million in milestone revenue and an EPS...
🟢 Connect Biopharma is trading 6.01% up today after Q2 collaboration revenue from Simcere regulatory milestone
Connect Biopharma is trading 6.01% up now at $2.47 after reporting second-quarter results with $2.8 million in collaboration revenue, versus minimal...
Connect Biopharma's second quarter 2026 results beat estimates as milestone revenue reached $2.8M
Connect Biopharma reported second quarter 2026 revenue of $2.8 million and a net loss per share of $0.27, outperforming consensus estimates. Results were...
🟢 Connect Biopharma is trading 5% up today ahead of August 12, 2026 earnings
Connect Biopharma is trading 5.13% up now at $2.35 after continued investor positioning ahead of the expected August 12, 2026, second-quarter earnings...
Connect Biopharma Surges 10% Before Earnings — But Can a Cash-Burning Biotech With No Revenue Justify the Optimism?
Shares of Connect Biopharma shifted sharply higher on August 11, climbing 10.7% to $2.38 ahead of the company's expected Q2 2026 earnings report on August 12....
🟢 Connect Biopharma is trading 10.7% up in pre-market ahead of its August 12, 2026 earnings report
Connect Biopharma is trading 10.7% up at $2.38 ahead of its Q2 2026 earnings report, expected on August 12, 2026. - Analysts expect a $0.32-per-share loss and...
Connect Biopharma Holdings Ltd Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Connect Biopharma is expected to report a Q2 2026 consensus loss of $0.32 per share on zero revenue, with the current $1.82 share price sitting significantly...
🟢 Connect Biopharma is trading 11.09% up in pre-market possibly ahead of August 12, 2026 earnings
Connect Biopharma is trading at $2.45 (+11.09%), with investors possibly positioning ahead of August 12, 2026 earnings. - No new company-specific announcement...
🟢 Connect Biopharma is trading 5.3% up today amid a broad biotech and risk-on rally
Connect Biopharma is trading 5.3% up at $2.18 today, extending its recent upside momentum amid a broad risk-on sentiment and a rally across biotech names. •...